European Molecular Biology Laboratory

The European Molecular Biology Laboratory (EMBL) is Europe's esteemed lab network for research in molecular biology. EMBL is funded by 20 member states an one associate member. EMBL operates in 5 sites, the main laboratory is in Heidelberg, Germany. Additionally, EMBL manages the European Bioinformatics Institute in Hinxton, Grenoble, Hamburg and Monterotondo near Rome, Italy. Research at EMBL covers the entire spectrum of research in molecular biology. The mission of EMBL is to train scientists at all levels, perform basic molecular biology research and to create new instruments and methods in the broad field of life science and technology development. EMBL has a PhD program and currently has 170 candidates in the program. EMBL publishes updates news about their current research and welcomes the public and media to visit or connect with them about their work.

Address
EMBL Heidelberg
Meyerhofstra?e 1
Heidelberg D-69117
Germany
E-mail
pressoffice@embl.de
Fax
+49 [0] 6221 387-8306
Some content from Wikipedia, licensed under CC BY-SA

Protecting us from our cells

Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes ...

Oct 22, 2014
popularity 5 / 5 (3) | comments 0

How plankton gets jet lagged

A hormone that governs sleep and jet lag in humans may also drive the mass migration of plankton in the ocean, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found. ...

Sep 26, 2014
popularity not rated yet | comments 0

Insights into genetics of cleft lip

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face. The study, published ...

May 27, 2014
popularity 4.5 / 5 (2) | comments 0

MIABE standard opens up new opportunities in drug discovery

An international consortium of pharmaceutical companies, public and commercial data providers and academic groups has agreed on a new standard for describing the effect of a compound on a biological entity. Published in Nature Re ...

Aug 31, 2011
popularity not rated yet | comments 0